Company News, Media Coverage 27 Jan 2026 MEDIA | Implicit Bioscience’s IC14 Granted FDA Fast Track Designation for Acute Decompensated Heart Failure Implicit Bioscience today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to IC14 (atibuclimab)… Implicit Bioscience
